Investing.com -- Celcuity Inc. (NASDAQ:CELC)股价上涨5.2%,此前这家临床阶段生物技术公司宣布将于2025年7月28日召开电话会议,公布其第三期VIKTORIA-1试验中PIK3CA野生型队列的初步结果。 这家总部位于明尼阿波利斯的公司将展示一项研究数据,该研究评估了gedatolisib与fulvestrant联合使用或不与palbociclib...
Source LinkInvesting.com -- Celcuity Inc. (NASDAQ:CELC)股价上涨5.2%,此前这家临床阶段生物技术公司宣布将于2025年7月28日召开电话会议,公布其第三期VIKTORIA-1试验中PIK3CA野生型队列的初步结果。 这家总部位于明尼阿波利斯的公司将展示一项研究数据,该研究评估了gedatolisib与fulvestrant联合使用或不与palbociclib...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.